Dr. Martin Burow is the founder of DMB-Diagnostics GmbH and an expert in medical cannabis and tumor diagnostics involving circulating tumor cells.
DMB-Diagnostics’ sales team is focused on unique diagnostic tests in the field of oncological companion diagnostics. DMB distributes the most advanced system for quantitative determination and monitoring of circulating tumor cells (CTCs) globally. This system (maintrac(R)) enables the identification of effective chemotherapy treatments prior to initiating therapy. There is a close collaboration with the medical specialist laboratory Dr. Pachmann.
Combining maintrac(R) drug testing with various cannabinoid solutions or other chemotherapeutics can selectively identify highly effective medical cannabis or other medication and subsequently monitor the treatment’s progress.
Our team is here for you.
Give us a call! Tel.: +49-172-3205601